Publications by authors named "Laura A Williams"

Claim this Profile
T
The role of serum phosphate control in supporting transplant readiness in patients on dialysis.
Laura A Williams, Stephen Z Fadem

Curr Med Res Opin· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allergen-Encapsulating Nanoparticles Reprogram Pathogenic Allergen-Specific Th2 Cells to Suppress Food Allergy.
Michael N Saunders, Laila M Rad, Laura A Williams, Jeffrey J Landers, Russell R Urie

Adv Healthc Mater· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building-Block Size Mediates Microporous Annealed Particle Hydrogel Tube Microenvironment Following Spinal Cord Injury.
Brian C Ross, Robert N Kent, Michael N Saunders, Samantha R Schwartz, Brooke M Smiley, Laura A Williams

Adv Healthc Mater· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy with biodegradable nanoparticles encapsulating the oligosaccharide galactose-alpha-1,3-galactose enhance immune tolerance against alpha-gal sensitization in a murine model of alpha-gal syndrome.
Michael N Saunders, Claudia M Rival, Mahua Mandal, Kayla Cramton, Laila M Rad, Laura A Williams

Front Allergy· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal Permeability, Irritable Bowel Syndrome with Constipation, and the Role of Sodium-Hydrogen Exchanger Isoform 3 (NHE3).
Brian E Lacy, David Rosenbaum, Susan Edelstein, Kenji Kozuka, Laura A Williams

Clin Exp Gastroenterol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biphasic pleural mesothelioma in a goat.
Lindsay M Fry, Johnathan DenHerder, Gay Lynn Clyde, Laura A Williams, David A Schneider

Can Vet J· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Patient Experience of Premenopausal Women Treated with Bremelanotide for Hypoactive Sexual Desire Disorder: RECONNECT Exit Study Results.
Patricia Koochaki, Dennis Revicki, Hilary Wilson, Robin Pokrzywinski, Robert Jordan, Laura A Williams

J Womens Health (Larchmt)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoactive sexual desire disorder (HSDD) is not "female erectile dysfunction (ED)": challenges with the characterization of HSDD in women based on a systematic literature review.
Sheryl A Kingsberg, Shruti Nambiar, Swagata Karkare, Nandini Hadker, Michelle Lim-Watson, Laura A Williams

Curr Med Res Opin· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.
Sheryl A Kingsberg, Anita H Clayton, David Portman, Laura A Williams, Julie Krop

Obstet Gynecol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder.
James A Simon, Sheryl A Kingsberg, David Portman, Laura A Williams, Julie Krop

Obstet Gynecol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST).
Michael H Davidson, Robert S Rosenson, Kevin C Maki, Stephen J Nicholls, Christie M Ballantyne, Laura A Williams

Arterioscler Thromb Vasc Biol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind study of fenofibric acid plus rosuvastatin compared with rosuvastatin alone in stage 3 chronic kidney disease.
Debra L Weinstein, Laura A Williams, Dawn M Carlson, Maureen T Kelly, Kim M Burns

Clin Ther· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-clinical response analysis of paricalcitol in patients with chronic kidney disease (stage 5) on hemodialysis or peritoneal dialysis.
Peter A Noertersheuser, Rajendra S Pradhan, Cheri E Klein, Laura A Williams, Rameshraja Palaparthy

J Clin Pharmacol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active commuting: prevalence, barriers, and associated variables.
Kelly Samara Silva, Daniel Giordani Vasques, Caroline de Oliveira Martins, Laura Ashley Williams, Adair S Lopes

J Phys Act Health· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular components in three breeds of dogs with high prevalence of myopia.
Laura A Williams, Melissa A Kubai, Christopher J Murphy, Donald O Mutti

Optom Vis Sci· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achievement of lipid targets with the combination of rosuvastatin and fenofibric Acid in patients with type 2 diabetes mellitus.
Robert S Rosenson, Dawn M Carlson, Maureen T Kelly, Carolyn M Setze, Boaz Hirshberg, Laura A Williams

Cardiovasc Drugs Ther· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of rosuvastatin 5 mg in combination with fenofibric acid 135 mg in patients with mixed dyslipidemia - a phase 3 study.
Eli M Roth, Robert S Rosenson, Dawn M Carlson, Sandra M Fukumoto, Carolyn M Setze, Laura A Williams

Cardiovasc Drugs Ther· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination rosuvastatin plus fenofibric acid in a cohort of patients 65 years or older with mixed dyslipidemia: subanalysis of two randomized, controlled studies.
Carl J Pepine, Terry A Jacobson, Dawn M Carlson, Maureen T Kelly, Carolyn M Setze, Laura A Williams

Clin Cardiol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.
Eli M Roth, James M McKenney, Maureen T Kelly, Carolyn M Setze, Dawn M Carlson, Laura A Williams

Am J Cardiovasc Drugs· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of paricalcitol and calcitriol on intestinal calcium absorption in hemodialysis patients.
Richard J Lund, Dennis L Andress, Michael Amdahl, Laura A Williams, Robert P Heaney

Am J Nephrol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Edward A Ross, Jin Tian, Hanna Abboud, Richard Hippensteel, Joel Z Melnick, Laura A Williams

Am J Nephrol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
Larry A Greenbaum, Nadine Benador, Stuart L Goldstein, Ana Paredes, Joel Z Melnick, Laura A Williams

Am J Kidney Dis· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of omeprazole on the pharmacokinetics of paricalcitol in healthy subjects.
Rameshraja Palaparthy, Rajendra S Pradhan, Jenny Chan, Matthew Rieser, Titus Chira, Laura A Williams

Biopharm Drug Dispos· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential role of active vitamin D in retarding the progression of chronic kidney disease.
Jin Tian, Youhua Liu, Laura A Williams, Dick de Zeeuw

Nephrol Dial Transplant· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4.
Hanna Abboud, Daniel Coyne, Olgierd Smolenski, Michael Anger, Norman Lunde, Laura A Williams

Am J Nephrol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis